Share Price and Basic Stock Data
Last Updated: November 6, 2025, 5:20 pm
| PEG Ratio | 0.39 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Frontline Corporation Ltd operates in the road transport industry, with a current share price of ₹38.2 and a market capitalization of ₹19.1 Cr. The company’s revenue from operations has shown a progressive trend, standing at ₹77 Cr for the fiscal year ending March 2023, which rose to ₹88 Cr for March 2024. The trailing twelve months revenue stood at ₹111 Cr, indicating a robust growth trajectory. Quarterly sales figures exhibit a consistent increase, with ₹22.84 Cr reported in June 2023 and reaching ₹25.34 Cr by December 2024. These figures suggest a strong demand for Frontline’s services, particularly as the company adapts to evolving market conditions. The operating profit margin (OPM) remained low at 2.51%, which is below the typical sector range, reflecting challenges in cost management. Overall, while the sales growth is promising, the company must address its profitability to enhance its competitive position.
Profitability and Efficiency Metrics
Frontline Corporation’s profitability measures indicate a mixed performance. The net profit for the fiscal year ending March 2025 was recorded at ₹3 Cr, with an earnings per share (EPS) of ₹5.80. The return on equity (ROE) stood at 14.6%, which is commendable compared to industry standards. However, the return on capital employed (ROCE) at 4.73% is relatively low, indicating that the company is not utilizing its capital as efficiently as it could. The interest coverage ratio (ICR) of 7.88x suggests that the company can comfortably meet its interest obligations, a positive sign for financial stability. The cash conversion cycle (CCC) of 60 days indicates that the company efficiently manages its receivables and inventory, although improvements could further enhance liquidity. The operating profit margin has fluctuated, with a low of -4.47% in March 2023, highlighting the need for cost control measures to improve overall profitability.
Balance Sheet Strength and Financial Ratios
Frontline Corporation’s balance sheet reflects a cautious financial position, with total borrowings reported at ₹57 Cr against reserves of ₹10 Cr. This results in a high total debt to equity ratio of 3.72, indicating significant leverage compared to typical industry standards. The current ratio of 0.51 and quick ratio of 0.33 suggest liquidity concerns, as the company may struggle to meet its short-term liabilities. The book value per share increased to ₹30.92 in March 2025, demonstrating a gradual strengthening of shareholder equity. The company’s fixed assets stood at ₹35 Cr, providing a solid asset base. However, the interest coverage ratio of 7.88x indicates that while the company can cover its interest expenses, the high level of debt poses risks. Overall, while the balance sheet shows some strengths, the high leverage and liquidity ratios warrant close monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Frontline Corporation Ltd shows a stable distribution, with promoters holding 47.19% and the public comprising 52.81% of the total shareholders, which numbered 1,413 as of June 2025. The promoter holding has seen a slight decline from 48.63% in March 2023, indicating a gradual shift towards greater public ownership. This could signal a growing investor confidence in the company, as evidenced by the increase in the number of shareholders from 916 in December 2022 to 1,413 in June 2025. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may imply a lack of institutional interest, which could limit the stock’s potential for broader market acceptance. Nonetheless, the steady public ownership suggests a solid retail investor base, which can provide stability in stock performance during volatile market conditions.
Outlook, Risks, and Final Insight
Looking ahead, Frontline Corporation faces both opportunities and challenges. The company has demonstrated consistent revenue growth, but its profitability metrics indicate the need for improved cost management and operational efficiency. Key risks include high leverage, as evidenced by a total debt to equity ratio of 3.72, which could hinder financial flexibility in adverse conditions. Additionally, liquidity concerns, highlighted by a current ratio of 0.51, pose risks to short-term operational stability. However, strengths such as an improving ROE of 14.6% and a growing shareholder base can provide a foundation for future growth. If Frontline can enhance its operational efficiency and manage its debt levels effectively, it may position itself for a stronger competitive advantage in the road transport sector. The company’s ability to navigate these risks while capitalizing on growth opportunities will be critical for its long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Frontline Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Frontline Corporation Ltd | 19.3 Cr. | 38.6 | 61.5/36.0 | 6.29 | 30.8 | 0.00 % | 4.73 % | 14.6 % | 10.0 |
| Coastal Roadways Ltd | 15.5 Cr. | 37.4 | 45.6/29.0 | 9.77 | 56.4 | 0.00 % | 9.25 % | 6.35 % | 10.0 |
| Balurghat Technologies Ltd | 31.4 Cr. | 17.3 | 36.8/15.2 | 30.5 | 9.56 | 0.00 % | 13.0 % | 12.7 % | 10.0 |
| ABC India Ltd | 43.8 Cr. | 80.9 | 134/78.1 | 25.6 | 101 | 0.62 % | 6.57 % | 4.15 % | 10.0 |
| Transport Corporation of India Ltd (TCI) | 8,875 Cr. | 1,137 | 1,309/875 | 20.4 | 276 | 0.70 % | 20.5 % | 19.8 % | 2.00 |
| Industry Average | 3,164.67 Cr | 157.09 | 26.14 | 114.16 | 0.15% | 11.99% | 10.77% | 8.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.95 | 15.56 | 19.60 | 20.56 | 22.84 | 21.27 | 21.18 | 22.56 | 24.86 | 25.26 | 25.34 | 28.50 | 31.49 |
| Expenses | 20.73 | 15.00 | 18.64 | 21.48 | 22.82 | 20.94 | 21.02 | 23.02 | 24.43 | 24.58 | 24.56 | 28.14 | 30.70 |
| Operating Profit | 0.22 | 0.56 | 0.96 | -0.92 | 0.02 | 0.33 | 0.16 | -0.46 | 0.43 | 0.68 | 0.78 | 0.36 | 0.79 |
| OPM % | 1.05% | 3.60% | 4.90% | -4.47% | 0.09% | 1.55% | 0.76% | -2.04% | 1.73% | 2.69% | 3.08% | 1.26% | 2.51% |
| Other Income | 0.76 | 0.70 | 0.73 | 2.22 | 0.73 | 0.79 | 0.87 | 0.96 | 0.78 | 1.07 | 0.81 | 1.70 | 0.73 |
| Interest | 0.01 | 0.01 | 0.01 | 0.08 | 0.01 | 0.01 | 0.02 | 0.18 | 0.21 | 0.20 | 0.18 | 0.25 | 0.22 |
| Depreciation | 0.38 | 0.39 | 0.41 | 0.42 | 0.42 | 0.42 | 0.38 | 0.38 | 0.47 | 0.49 | 0.49 | 0.74 | 0.56 |
| Profit before tax | 0.59 | 0.86 | 1.27 | 0.80 | 0.32 | 0.69 | 0.63 | -0.06 | 0.53 | 1.06 | 0.92 | 1.07 | 0.74 |
| Tax % | 25.42% | 23.26% | 24.41% | 21.25% | 59.38% | 37.68% | 34.92% | -533.33% | 28.30% | 13.21% | 23.91% | 17.76% | 22.97% |
| Net Profit | 0.44 | 0.67 | 0.97 | 0.63 | 0.14 | 0.42 | 0.41 | 0.25 | 0.39 | 0.91 | 0.71 | 0.88 | 0.57 |
| EPS in Rs | 0.88 | 1.34 | 1.94 | 1.26 | 0.28 | 0.84 | 0.82 | 0.50 | 0.78 | 1.82 | 1.42 | 1.76 | 1.14 |
Last Updated: August 19, 2025, 3:10 pm
Below is a detailed analysis of the quarterly data for Frontline Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 31.49 Cr.. The value appears strong and on an upward trend. It has increased from 28.50 Cr. (Mar 2025) to 31.49 Cr., marking an increase of 2.99 Cr..
- For Expenses, as of Jun 2025, the value is 30.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.14 Cr. (Mar 2025) to 30.70 Cr., marking an increase of 2.56 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.36 Cr. (Mar 2025) to 0.79 Cr., marking an increase of 0.43 Cr..
- For OPM %, as of Jun 2025, the value is 2.51%. The value appears strong and on an upward trend. It has increased from 1.26% (Mar 2025) to 2.51%, marking an increase of 1.25%.
- For Other Income, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 0.97 Cr..
- For Interest, as of Jun 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.25 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 0.56 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.56 Cr., marking a decrease of 0.18 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.74 Cr.. The value appears to be declining and may need further review. It has decreased from 1.07 Cr. (Mar 2025) to 0.74 Cr., marking a decrease of 0.33 Cr..
- For Tax %, as of Jun 2025, the value is 22.97%. The value appears to be increasing, which may not be favorable. It has increased from 17.76% (Mar 2025) to 22.97%, marking an increase of 5.21%.
- For Net Profit, as of Jun 2025, the value is 0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 0.88 Cr. (Mar 2025) to 0.57 Cr., marking a decrease of 0.31 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.14. The value appears to be declining and may need further review. It has decreased from 1.76 (Mar 2025) to 1.14, marking a decrease of 0.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:20 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 38 | 38 | 43 | 44 | 47 | 48 | 59 | 72 | 77 | 88 | 104 | 111 |
| Expenses | 40 | 36 | 38 | 46 | 44 | 47 | 50 | 58 | 71 | 76 | 88 | 102 | 108 |
| Operating Profit | 2 | 1 | 0 | -2 | -0 | -1 | -2 | 1 | 0 | 1 | 0 | 2 | 3 |
| OPM % | 5% | 3% | 1% | -5% | -0% | -1% | -4% | 1% | 0% | 1% | 0% | 2% | 2% |
| Other Income | 4 | 3 | 1 | 10 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 |
| Interest | 6 | 5 | 5 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | -1 | -2 | -5 | 1 | 2 | -1 | -1 | 1 | 2 | 4 | 2 | 4 | 4 |
| Tax % | -87% | -11% | -18% | 33% | 17% | -35% | -16% | 12% | 21% | 23% | 22% | 19% | |
| Net Profit | -0 | -2 | -4 | 1 | 2 | -0 | -1 | 1 | 1 | 3 | 1 | 3 | 3 |
| EPS in Rs | -0.34 | -3.66 | -8.50 | 1.70 | 3.84 | -0.66 | -1.98 | 2.30 | 2.90 | 5.42 | 2.44 | 5.78 | 6.14 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -100.00% | 125.00% | 100.00% | -100.00% | 200.00% | 0.00% | 200.00% | -66.67% | 200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 225.00% | -25.00% | -200.00% | 300.00% | -200.00% | 200.00% | -266.67% | 266.67% |
Frontline Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | 13% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 32% |
| 3 Years: | 12% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 40% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 7 | 5 | 1 | 0 | 2 | 2 | 1 | 2 | 4 | 6 | 8 | 10 |
| Borrowings | 38 | 45 | 39 | 51 | 54 | 53 | 53 | 52 | 49 | 49 | 57 | 57 |
| Other Liabilities | 24 | 19 | 32 | 17 | 15 | 15 | 10 | 6 | 6 | 6 | 8 | 9 |
| Total Liabilities | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 |
| Fixed Assets | 27 | 26 | 28 | 32 | 35 | 33 | 34 | 32 | 31 | 30 | 34 | 35 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
| Investments | 7 | 7 | 7 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 0 |
| Other Assets | 40 | 40 | 42 | 40 | 41 | 41 | 35 | 32 | 32 | 34 | 40 | 46 |
| Total Assets | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 |
Below is a detailed analysis of the balance sheet data for Frontline Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
- For Reserves, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Mar 2025, the value is 57.00 Cr.. The value remains steady. However, Borrowings exceed Reserves, which may signal higher financial risk. There is no change compared to the previous period (Mar 2024) which recorded 57.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 5.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Mar 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 5.00 Cr..
However, the Borrowings (57.00 Cr.) are higher than the Reserves (10.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | -44.00 | -39.00 | -53.00 | -54.00 | -54.00 | -55.00 | -51.00 | -49.00 | -48.00 | -57.00 | -55.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 74 | 66 | 77 | 82 | 66 | 57 | 57 | 42 | 39 | 38 | 39 |
| Inventory Days | 169 | 213 | 208 | 130 | 141 | 142 | 88 | 40 | 35 | 47 | 48 | 53 |
| Days Payable | 242 | 200 | 64 | 203 | 216 | 192 | 100 | 38 | 24 | 24 | 28 | 32 |
| Cash Conversion Cycle | 1 | 86 | 209 | 4 | 7 | 16 | 45 | 59 | 53 | 61 | 59 | 60 |
| Working Capital Days | -291 | -365 | -348 | -273 | -246 | -237 | -252 | -204 | -161 | -147 | -136 | -108 |
| ROCE % | 4% | 5% | 0% | 11% | 4% | -0% | -1% | 3% | 4% | 4% | 2% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Diluted EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Cash EPS (Rs.) | 10.21 | 5.67 | 8.65 | 6.43 | 6.34 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Revenue From Operations / Share (Rs.) | 208.85 | 176.49 | 154.04 | 144.14 | 117.74 |
| PBDIT / Share (Rs.) | 13.28 | 6.83 | 10.51 | 7.78 | 7.51 |
| PBIT / Share (Rs.) | 8.87 | 3.59 | 7.30 | 4.26 | 3.47 |
| PBT / Share (Rs.) | 7.18 | 3.15 | 7.09 | 3.70 | 2.62 |
| Net Profit / Share (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| PBDIT Margin (%) | 6.35 | 3.86 | 6.82 | 5.39 | 6.37 |
| PBIT Margin (%) | 4.24 | 2.03 | 4.74 | 2.95 | 2.94 |
| PBT Margin (%) | 3.44 | 1.78 | 4.59 | 2.56 | 2.22 |
| Net Profit Margin (%) | 2.77 | 1.38 | 3.53 | 2.02 | 1.95 |
| Return on Networth / Equity (%) | 18.77 | 9.72 | 23.90 | 16.88 | 16.04 |
| Return on Capital Employeed (%) | 19.51 | 8.43 | 29.19 | 23.00 | 17.80 |
| Return On Assets (%) | 3.52 | 1.57 | 4.07 | 2.28 | 1.77 |
| Long Term Debt / Equity (X) | 0.47 | 0.69 | 0.09 | 0.07 | 0.35 |
| Total Debt / Equity (X) | 3.72 | 4.56 | 4.34 | 5.69 | 7.08 |
| Asset Turnover Ratio (%) | 1.31 | 1.22 | 1.18 | 1.12 | 0.88 |
| Current Ratio (X) | 0.51 | 0.54 | 0.48 | 0.44 | 0.44 |
| Quick Ratio (X) | 0.33 | 0.38 | 0.35 | 0.35 | 0.36 |
| Inventory Turnover Ratio (X) | 10.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 7.88 | 15.24 | 48.34 | 13.75 | 8.86 |
| Interest Coverage Ratio (Post Tax) (X) | 4.44 | 6.45 | 26.04 | 6.15 | 3.72 |
| Enterprise Value (Cr.) | 76.12 | 75.35 | 60.46 | 61.41 | 54.17 |
| EV / Net Operating Revenue (X) | 0.73 | 0.85 | 0.78 | 0.85 | 0.92 |
| EV / EBITDA (X) | 11.52 | 22.18 | 11.56 | 15.87 | 14.49 |
| MarketCap / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| Price / BV (X) | 1.33 | 1.55 | 1.07 | 1.57 | 0.67 |
| Price / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| EarningsYield | 0.14 | 0.06 | 0.22 | 0.10 | 0.23 |
After reviewing the key financial ratios for Frontline Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 5.67 (Mar 24) to 10.21, marking an increase of 4.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 208.85. It has increased from 176.49 (Mar 24) to 208.85, marking an increase of 32.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 6.83 (Mar 24) to 13.28, marking an increase of 6.45.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 8.87, marking an increase of 5.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.18. This value is within the healthy range. It has increased from 3.15 (Mar 24) to 7.18, marking an increase of 4.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For PBDIT Margin (%), as of Mar 25, the value is 6.35. This value is below the healthy minimum of 10. It has increased from 3.86 (Mar 24) to 6.35, marking an increase of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.24. This value is below the healthy minimum of 10. It has increased from 2.03 (Mar 24) to 4.24, marking an increase of 2.21.
- For PBT Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 10. It has increased from 1.78 (Mar 24) to 3.44, marking an increase of 1.66.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 2.77, marking an increase of 1.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.77. This value is within the healthy range. It has increased from 9.72 (Mar 24) to 18.77, marking an increase of 9.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.51. This value is within the healthy range. It has increased from 8.43 (Mar 24) to 19.51, marking an increase of 11.08.
- For Return On Assets (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 1.57 (Mar 24) to 3.52, marking an increase of 1.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has decreased from 0.69 (Mar 24) to 0.47, marking a decrease of 0.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 1. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has increased from 1.22 (Mar 24) to 1.31, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1.5. It has decreased from 0.54 (Mar 24) to 0.51, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.33, marking a decrease of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.79. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 10.79, marking an increase of 10.79.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.88. This value is within the healthy range. It has decreased from 15.24 (Mar 24) to 7.88, marking a decrease of 7.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.44. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 4.44, marking a decrease of 2.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 76.12. It has increased from 75.35 (Mar 24) to 76.12, marking an increase of 0.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.73, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 25, the value is 11.52. This value is within the healthy range. It has decreased from 22.18 (Mar 24) to 11.52, marking a decrease of 10.66.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.55 (Mar 24) to 1.33, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.14, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Frontline Corporation Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.51% (Industry Average ROCE: 11.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.77% (Industry Average ROE: 10.77%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6.29 (Industry average Stock P/E: 26.14)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.72
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Transport - Road | 4, B.B.D Bag (East), Stephen House, Kolkata West Bengal 700001 | frontlinecorplimited@gmail.com http://www.frontlinecorporation.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ram Prasad Agarwal | Chairman & Director |
| Mr. Pawan Kumar Agarwal | Managing Director |
| Mr. Narayan Prasad Agarwal | Director |
| Mr. Saurabh Jhunjhunwala | Director |
| Mrs. Dipika Pradeep Soni | Independent Woman Director |
| Mr. Dipen Ashit Dalal | Independent Director |
| Ms. Aarefa Kutub Kapasi | Independent Woman Director |
| Mrs. Ummay Amen Mashraqi | Independent Woman Director |
FAQ
What is the intrinsic value of Frontline Corporation Ltd?
Frontline Corporation Ltd's intrinsic value (as of 07 November 2025) is 23.08 which is 40.21% lower the current market price of 38.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 19.3 Cr. market cap, FY2025-2026 high/low of 61.5/36.0, reserves of ₹10 Cr, and liabilities of 82 Cr.
What is the Market Cap of Frontline Corporation Ltd?
The Market Cap of Frontline Corporation Ltd is 19.3 Cr..
What is the current Stock Price of Frontline Corporation Ltd as on 07 November 2025?
The current stock price of Frontline Corporation Ltd as on 07 November 2025 is 38.6.
What is the High / Low of Frontline Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Frontline Corporation Ltd stocks is 61.5/36.0.
What is the Stock P/E of Frontline Corporation Ltd?
The Stock P/E of Frontline Corporation Ltd is 6.29.
What is the Book Value of Frontline Corporation Ltd?
The Book Value of Frontline Corporation Ltd is 30.8.
What is the Dividend Yield of Frontline Corporation Ltd?
The Dividend Yield of Frontline Corporation Ltd is 0.00 %.
What is the ROCE of Frontline Corporation Ltd?
The ROCE of Frontline Corporation Ltd is 4.73 %.
What is the ROE of Frontline Corporation Ltd?
The ROE of Frontline Corporation Ltd is 14.6 %.
What is the Face Value of Frontline Corporation Ltd?
The Face Value of Frontline Corporation Ltd is 10.0.